Investor Overview

An IP Platform

Asset-Light · Recurring Royalty · Pre-Revenue

Fund the bridge from computational validation to physical proof, and participate in an asset-light licensing business with recurring royalty economics across the Americas.

● Pre-Revenue · TRL 3 ● Provisional Patent Application Filed with USPTO ● Seeking Prototype Capital

Request Investor Briefing

Where We Are

The Strongest Possible Licensing Position

Pre-revenue with validated technology is leverage, not weakness. The provisional patent application, now filed with the USPTO, establishes priority. No licensee has claimed preferred terms; no field-of-use is carved out; no royalty precedent constrains future deals. The first partners receive the most favorable terms that will ever exist for this technology.

0/77

Cells Validated

Full parametric sweep optimal across all RPM × species combinations.

Patent Claim Families

Independently patentable, independently licensable innovations.

~$15M

Risk-Adjusted Value Today

Indicative pre-revenue enterprise value; re-rates on physical validation.

$75–200K

Capital Sought

Prototype fabrication + independent validation + non-provisional filing.

Market Opportunity

A Large, Growing, Recurring Market

Blades are a consumable — replaced every 4–8 weeks on commercial mowers during peak season. The revenue is structurally recurring, built into the physics of blade wear.

Recurring by Physics

Commercial blade replacement every 4–8 weeks — recurring revenue without a subscription.

Global rotary mower market	$33.66B → $48.60B by 2030
Market CAGR	6.6% (Grand View Research)
Commercial ZTR blade aftermarket	15–35M blades/yr · Americas
Agricultural mowers (secondary tree)	$2.26B → $3.19B by 2032
OPE long-run CAGR	5.58% (2026–2034)

Market figures from third-party syndicated research. Vortex_X capture projections are in the confidential investor package.

Interactive · Licensing Economics

Royalty Revenue Modeler

Model the recurring-royalty economics of the platform at different adoption volumes. Illustrative planning estimates, not an offer.

Annual Blades (all licensees) 500,000

Wholesale Price / Blade $10.00

Royalty Rate 5.0%

Upfront License Fees $1,000,000

Royalty / Blade—

Annual Royalty Revenue—

10-Year Cumulative—

Indicative EV (8× EBITDA)—

Illustrative model for discussion only. EBITDA margin and exit-multiple assumptions are planning estimates and do not constitute a valuation, an offer of securities, or investment advice.

Business Model

Asset-Light Licensing Economics

Vortex_X owns the IP and licenses it; partners manufacture and distribute. No factories, no inventory, no working capital — royalty revenue at IP-platform margins.

Upfront License Fees

Paid by each OEM on commercial license execution. First-licensee terms set the founding benchmark.

Per-Unit Running Royalties

A royalty on every blade shipped — recurring, perpetual, indexed to a high-frequency consumable cycle.

Minimum Annual Royalties

Ramping guarantees that prevent shelving and provide revenue-floor predictability.

Multiple Field-of-Use Trees

Commercial turf, residential, agricultural, and municipal — each an independent licensing opportunity.

Use of Funds

What This Round Builds

Prototype and validation capital — the bridge from computational results (TRL 3) to physically validated performance (TRL 6) and the first OEM field pilot.

Prototype Fabrication

First-generation MARBAIN®-class steel / MARBAIN®-class assemblies.

Independent Validation

Third-party bench testing: balance, airflow, cut quality.

Patent & IP

Non-provisional filing plus PCT (Mexico, Brazil, Argentina).

OEM Pilot Setup

Field-evaluation program with first OEM partner fleet.

Non-Dilutive Parallel Track

A USDA SBIR Phase I application (up to $175K non-dilutive) runs concurrently, alongside enrollment in manufacturing accelerator programs (NIST MEP / NextCorps). Combined, these can reach prototype and validation milestones while minimizing equity dilution.

Investor Position

Entry Before the Re-Rate

Preferred equity position in the IP platform company at the pre-validation stage.
First-look rights on the commercial licensing term sheet before any OEM partner conversation.
Pro-rata participation rights in any future institutional round.
Entry at today's indicative ~$15M risk-adjusted valuation — ahead of the physical-validation milestones expected to re-rate the asset.

All valuation figures are indicative and provided for discussion only. They are not an offer to sell or a solicitation to buy any security, and do not constitute investment advice. Performance figures are computational engineering results pending physical validation. Any investment would be made solely pursuant to definitive confidential offering materials.

Confidential · Qualified Investors Only

Request the Investor Package

The full investor deck, financial model, valuation framework, and patent claim structure are shared with qualified investors under NDA.